Ligand Pharma (LGND) Misses Q4 EPS by 45c
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $281.72 +0.55%
Financial Fact:
Income tax expense (benefit): -160K
Today's EPS Names:
ARDS, SQZB, MDRX, More
Financial Fact:
Income tax expense (benefit): -160K
Today's EPS Names:
ARDS, SQZB, MDRX, More
Join SI Premium – FREE
Ligand Pharma (NASDAQ: LGND) reported Q4 EPS of $0.74, $0.45 worse than the analyst estimate of $1.19. Revenue for the quarter came in at $38.2 million versus the consensus estimate of $40.34 million.
GUIDANCE:
Ligand Pharma sees FY2017 EPS of $2.70.
For earnings history and earnings-related data on Ligand Pharma (LGND) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
- Gordon Haskett cuts Dick's Sporting Goods price target to $130
- Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
